Cargando…
Randomized trial of intravenous versus bidirectional chemotherapy after cytoreductive surgery for malignant peritoneal mesothelioma
BACKGROUND: Malignant peritoneal mesothelioma (MPM) is a rare disease that progresses within the peritoneal cavity and only disseminates to systemic sites in the terminal months of the disease. For this malignancy, there are several regimens of chemotherapy that have been accepted as standard, princ...
Autor principal: | Sugarbaker, Paul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688535/ https://www.ncbi.nlm.nih.gov/pubmed/38046900 http://dx.doi.org/10.1097/SP9.0000000000000010 |
Ejemplares similares
-
Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012) -
Bidirectional chemotherapy allowing surgery and HIPEC for malignant peritoneal mesothelioma
por: Noiret, Barbara, et al.
Publicado: (2019) -
Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
por: Casado-Adam, Angela, et al.
Publicado: (2011) -
Unusual radiologic presentations of malignant peritoneal mesothelioma
por: Sugarbaker, Paul Hendrick, et al.
Publicado: (2020) -
Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020)